← Leaderboards
Hector M Colon
Universidad Central Del Caribe
$4,170,068
Attributed
$4,358,516
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $787K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,358,516 · 4
By mechanism
R01$2,950,380 · 1
R24$634,395 · 1
R21$396,845 · 1
U54$376,896 · 1
Top collaborators
- Carlos A. Luciano2 shared
Most similar at Universidad Central Del Caribe
Same institution · by research overlap
- Luis Vila$634,395
- Rafaela R Robles$3,899,433
- Robert Hunter$4,555,263
- Maria A Gomez$2,376,372
Others in their field
Top investigators on “Behavioral /Social Science Research Tag”
- Willard Cates · Family Health International$73,520,657
- Norman Wolmark · Nsabp Foundation, Inc.$67,161,981
- Robert J Willis · University Of Michigan At Ann Arbor$64,770,100
- Stephen A Spector · University Of California, San Diego$59,875,103
- Lloyd D Johnston · University Of Michigan At Ann Arbor$33,778,046
- Gregory H Reaman · National Childhood Cancer Foundation$29,150,052
Research focus
Behavioral /Social Science Research TagHigh Risk Behavior /LifestyleClinical ResearchDisease /Disorder Proneness /RiskIntravenous Drug AbuseHuman SubjectSubstance Abuse Related BehaviorHiv InfectionsHepatitis VirusCrack CocaineSubstance Abuse EpidemiologySexually Transmitted DiseasesSmokingLongitudinal Human StudyInhalation Drug AbuseNeedle SharingDrug AbuseHeroinPuerto RicanDrug Administration RoutesInterviewCultural SensitivityCommunity SettingEvidence Based Intervention
Grant awards (11)
COMMUNITY- BASED RESEARCH$188,447
U54 · FY2018 · MD · contact PI
COMMUNITY- BASED RESEARCH$188,449
U54 · FY2017 · MD · contact PI
Introducing New drug Preparation Materials to Reduce HIV/HCV Transmission Among$211,808
R21 · FY2006 · DA · contact PI
HIV Risks and Transitions to Injection among Non-IDUs$601,994
R01 · FY2005 · DA
New Drug Preparation Materials to Reduce HIV/HCV$185,037
R21 · FY2005 · DA
HIV Risks and Transitions to Injection among Non-IDUs$844,668
R01 · FY2004 · DA
HIV Risks and Transitions to Injection among Non-IDUs$865,977
R01 · FY2003 · DA
HIV Risks and Transitions to Injection among Non-IDUs$637,741
R01 · FY2002 · DA
HIV risk behaviors in preparation of injectable drugs$211,465
R24 · FY2002 · DA
HIV risk behaviors in preparation of injectable drugs$211,465
R24 · FY2001 · DA
HIV risk behaviors in preparation of injectable drugs$211,465
R24 · FY2000 · DA